Skip to Content

Menostar Approval History

FDA Approved: Yes (First approved June 8, 2004)
Brand name: Menostar
Generic name: estradiol transdermal system
Company: Berlex
Treatment for: Prevention of Osteoporosis

Menostar (estradiol transdermal system) is an estrogen patch for the prevention of postmenopausal osteoporosis.

Development History and FDA Approval Process for Menostar

DateArticle
Jun  8, 2004Approval Menostar Berlex - Treatment for Osteoporosis Prevention

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide